Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

MP0533 (CD33 x CD123 x CD70 x CD3), a Tetra-Specific CD3-Engaging Darpin for the Treatment of Patients with Relapsed/Refractory AML or MDS/AML: Results of an Ongoing Phase 1/2a Study

Blood (2024) 144 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2024-199211

Published: 2024

Journal Articles

MP0533, a CD3-Engaging Darpin Targeting CD33, CD123, and CD70 in Patients with Relapsed/Refractory AML or MDS/AML: Preliminary Results of a Phase 1/2a Study

Thomas Pabst, Mojca Jongen-Lavrencic, Steffen Boettcher, Geert A. Huls, David C. de Leeuw, Philippe Legenne, Mariola Dymkowska, Christiane Andrieu, Oliver Schönborn-Kellenberger, Paul G. Baverel, Zita Arany, Elena Fernandez, Anne Goubier, Vladimir Kirkin, Nicolas Leupin, Marion Subklewe

Blood (2023) 142 (Supplement 1): 2921.

https://doi.org/10.1182/blood-2023-173353

Published: 2023

Journal Articles

Safety and Efficacy of CD37-Targeting Naratuximab Emtansine PLUS Rituximab in Diffuse Large B-Cell Lymphoma and Other NON-Hodgkin'S B-Cell Lymphomas - a Phase 2 Study

Moshe Y. Levy, Deepa Jagadeesh, Zhanet Grudeva-Popova, Marek Trněný, Wojciech Jurczak, Halyna Pylypenko, Marc André, Sunita Dwivedy Nasta, Dalit Rechavi-Robinson, Sara Toffanin, Sandrine Micallef, Antoine Attinger, Elisabeth Rouits, Marie-Claude Roubaudi-Fraschini, Panos Orfanos, Mariola Dymkowska, Heidi Nauwelaerts, Sherida Woei-a-Jin

Blood (2021) 138 (Supplement 1): 526.

https://doi.org/10.1182/blood-2021-145102

Published: 2021